Abstract:The detection of mutations in the KRAS gene highly associated with cancer is one of the most widely used Sanger sequencing capillary electrophoresis (CE) applications in molecular diagnostics. In addition to their traditional role in cancer diagnostic, KRAS mutations have recently gained additional relevance as pharmacogenomics (PGx) markers for a significant number of new oncology therapeutics. KRAS mutation detection assays are used as companion diagnostics (CDx) for these cancer treatments. Analysis by Sanger Sequencing of KRAS mutations is cost effective and lends itself for use in resource limited healthcare settings. While there are currently no commercial kits for targeted sequencing of the KRAS mutation hotspots available, the online Applied Biosystems Primer DesignerTM Tool (thermofisher.com) allows standardization of the PCR primer design between labs and repeat orders of the KRAS assays by using these commercially available assay ID numbers. Here we demonstrate the use of Primer Designer KRAS mutation detections assays for mutation in codon 12, 13 and 61 totaling to 8 allele variants. The data was generated on the SeqStudio Flex CE instrument using reference standard DNA as well as DNA extracted from FFPE solid tumor samples. We show accuracy of variant call (OPA 100% (64/64)) and concordance (OPA 98.3% (59/60)) in a side-by-side comparison of the SeqStudio Flex with the legacy Model 3500 Genetic Analyzer instrument using a set of commercially available (Horizon Discovery) KRAS reference DNA samples. Primary solid tumor samples are processed to Fresh Frozen Paraffin Embedded samples (FFPE) for further disease marker evaluation. These samples are stable for long term at ambient temperatures and provide the opportunity to evaluate prospective biomarkers at large scale to understand their potential utility. Discovery Life Sciences has generated a large-scale biorepository of human biospecimen, including FFPE, plasma/sera, buffy coat, and PBMCs. Archival FFPE samples from oncology indications associated with KRAS mutations, such as non-small cell lung cancer and colorectal cancer, were analyzed and identified samples with KRAS mutations, demonstrating the potential diagnostic utility of these assays. Finally, cell-free (cf) DNA from double spun plasma from relevant indications was also successfully evaluated for KRAS mutations, highlighting the potential for these assays in liquid biopsy studies. The study demonstrates the robustness of the Primer Designer KRAS mutation detection sequencing assays using reference standard DNA as well as DNA derived from FFPE DNA and cfDNA from patient derived tumor samples. For Research Use Only. Not for use in diagnostic procedures. Citation Format: Achim Karger, Ami Patel, Kaylee Tseng, Camila Ornelas, Mary Napier, Rod Beck, Kerri Collwell, Shawn Fahl, Carole Bornarth. KRAS mutation detection by Sanger sequencing using the SeqStudio Flex capillary electrophoresis instrument [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6423.

The Rapid Detection of PCR-SSCP Analysis Using Fluorescently Labeled Primers.

Advance in PCR-SSCP and Its Application

Rapid detection of K-ras oncogene point mutation by real-time fluorescence allele-specific amplification

High fidelity SNP genotyping using sequence-specific primer elongation and fluorescence correlation spectroscopy

Lateral flow strip for visual detection of K-ras mutations based on allele-specific PCR

K-ras Point Mutation Detection in Colorectal Cancer:Comparison of Two Approaches Using Allele Specific Amplification

Homogeneous and Label-Free Fluorescence Detection of Single-Nucleotide Polymorphism Using Target-Primed Branched Rolling Circle Amplification

A Novel Mutant Allele Specific Amplification and Electrochemiluminescence Method for the Detection of Point Mutation in Clinical Samples.

Snapback Primer Mediated Clamping Pcr for Detection of Egfr and Kras Mutations in Nsclc Patients by High Resolution Melting Analysis

Rapid and Sensitive Detection of KRAS Mutation after Fast-Cold-pcr Enrichment and High-Resolution Melting Analysis.

An Automated Fluorescent Single Strand Conformation Polymorphism Technique for High Throughput Mutation Screening.

An Ecl-Pcr Method For Quantitative Detection Of Point Mutation

Quantitative Detection of H-ras Point Mutation in Bladder Cancer by ECL-PCR Method

Highly Sensitive ECL-PCR Method for Detection of K-ras Point Mutation

[High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer]

Sensitive Detection of Point Mutation Using Exponential Strand Displacement Amplification-Based Surface Enhanced Raman Spectroscopy

Abstract 6423: KRAS mutation detection by Sanger sequencing using the SeqStudio Flex capillary electrophoresis instrument

KRAS Mutation Detection Method Based on LNA and Allele Specific Amplification

Homogeneous and one-step fluorescent allele-specific PCR for SNP genotyping assays using conjugated polyelectrolytes.

Eprobe-mediated screening system for somatic mutations in the KRAS locus

Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions.